Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Joseph Donahue; Michael Wyzga; Patrick Finn

Joseph Donahue

BioReference Laboratories has hired Joseph Donahue to serve as senior vice president of the company's new Commercial Collaborations and Innovations group, which will focus on providing solutions that support pharmaceutical innovation, development, and go-to-market activities.

Previously, Donahue was senior vice president and global head of Thomson Reuters' Business Development and Innovation unit, where he led efforts to build a life sciences business that provided competitive intelligence, big data information solutions, intellectual property, and consulting services to industry and academia. He's spent much of his 30-year career working on providing life sciences organizations with informatics solutions that help speed up their research and development efforts.

Michael Wyzga

Exact Sciences has increased the size of its board to 10 directors and appointed Michael Wyzga to fill the spot. Wyzga will serve as a Class III director and be on Exact's audit committee until the firm's 2015 annual meeting. Between 2011 and 2013, he was the president and CEO of Radius Health, where he was also a board member. Prior to that, he held various management positions at Genzyme. Wyzga currently is a director at Akebia Therapeutics and Oncomed Pharmaceuticals.

Patrick Finn

Twist Bioscience named Patrick Finn vice president of sales and marketing. He joins the company as it prepares to launch its synthetic biology platform services this year. Finn was previously at Enzymatics, where he was VP of sales and marketing. Prior to that, he was director of business development at Agilent Technologies, director of product development at Beckman Coulter Molecular Diagnostics, and held various positions at Invitrogen and GE Healthcare/Amersham International.

For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.